Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges with supply chain costs.
Johnson & Johnson (NYSE: JNJ) stock fell 1.5%, weighed by a hefty dip in sales of its blockbuster psoriasis treatment Stelara, even as the pharmaceutical firm posted better-than-expected fourth-quarter adjusted earnings and sales.
Procter & Gamble beat second-quarter results estimates on Wednesday, driven by growing demand for its household items such as Pantene shampoos and Tide detergents as product innovations across price tiers helped lure more U.
Elon Musk is already casting doubt on OpenAI’s new, up to $500 billion investment deal with SoftBank (SFTBY) and Oracle (ORCL), despite backing from his allies — including President Donald Trump.
The Wall Street major averages advanced on Wednesday, with Nasdaq Composite (COMP:IND) in particular getting a big boost from Netflix (NFLX). The streaming giant popped after announcing robust quarterly results.
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of
In a report released yesterday, Robert Ottenstein from Evercore ISI maintained a Buy rating on Procter & Gamble (PG – Research Report),
Get ready for Wednesday's trading day that will be colored by AI enthusiasm and big-tech earnings expectations.